125 related articles for article (PubMed ID: 18210737)
1. [The effectiveness of montelukast in recurrent post-bronchiolitis wheezing].
Nanulescu M; Popescu L; Farcău M; Ichim G
Pneumologia; 2003; 52(3-4):213-6. PubMed ID: 18210737
[TBL] [Abstract][Full Text] [Related]
2. A randomized intervention of montelukast for post-bronchiolitis: effect on eosinophil degranulation.
Kim CK; Choi J; Kim HB; Callaway Z; Shin BM; Kim JT; Fujisawa T; Koh YY
J Pediatr; 2010 May; 156(5):749-54. PubMed ID: 20171653
[TBL] [Abstract][Full Text] [Related]
3. Systematic review of montelukast's efficacy for preventing post-bronchiolitis wheezing.
Peng WS; Chen X; Yang XY; Liu EM
Pediatr Allergy Immunol; 2014 Mar; 25(2):143-50. PubMed ID: 24118637
[TBL] [Abstract][Full Text] [Related]
4. Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children.
Bisgaard H; Flores-Nunez A; Goh A; Azimi P; Halkas A; Malice MP; Marchal JL; Dass SB; Reiss TF; Knorr BA
Am J Respir Crit Care Med; 2008 Oct; 178(8):854-60. PubMed ID: 18583576
[TBL] [Abstract][Full Text] [Related]
5. Montelukast does not prevent reactive airway disease in young children hospitalized for RSV bronchiolitis.
Proesmans M; Sauer K; Govaere E; Raes M; De Bilderling G; De Boeck K
Acta Paediatr; 2009 Nov; 98(11):1830-4. PubMed ID: 19659463
[TBL] [Abstract][Full Text] [Related]
6. The effect of montelukast on early-life wheezing: A randomized, double-blinded placebo-controlled study.
Keskin O; Arik Yilmaz E; Motzkus C; Sackesen C; Lilly CM; Kalayci O
Pediatr Allergy Immunol; 2018 Feb; 29(1):50-57. PubMed ID: 29047178
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, placebo-controlled, randomized trial of montelukast for acute bronchiolitis.
Amirav I; Luder AS; Kruger N; Borovitch Y; Babai I; Miron D; Zuker M; Tal G; Mandelberg A
Pediatrics; 2008 Dec; 122(6):e1249-55. PubMed ID: 18984650
[TBL] [Abstract][Full Text] [Related]
8. RCT of montelukast as prophylaxis for upper respiratory tract infections in children.
Kozer E; Lotem Z; Elgarushe M; Torgovicky R; Cohen R; Cohen HA; Berkovitch M
Pediatrics; 2012 Feb; 129(2):e285-90. PubMed ID: 22218843
[TBL] [Abstract][Full Text] [Related]
9. Use of montelukast in the treatment of early childhood wheezing from clinical experience with three cases.
Ng DK; Law AK; Chau KW; Chan HK
Respirology; 2000 Dec; 5(4):389-92. PubMed ID: 11192552
[TBL] [Abstract][Full Text] [Related]
10. A meta-analysis of montelukast for recurrent wheeze in preschool children.
Hussein HR; Gupta A; Broughton S; Ruiz G; Brathwaite N; Bossley CJ
Eur J Pediatr; 2017 Jul; 176(7):963-969. PubMed ID: 28567533
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
Szefler SJ; Baker JW; Uryniak T; Goldman M; Silkoff PE
J Allergy Clin Immunol; 2007 Nov; 120(5):1043-50. PubMed ID: 17983871
[TBL] [Abstract][Full Text] [Related]
12. Leukotriene receptor antagonists (Montelukast) in the treatment of asthma crisis: preliminary results of a double-blind placebo controlled randomized study.
Ferreira MB; Santos AS; Pregal AL; Michelena T; Alonso E; de Sousa AV; Pereira E; Palma-Carlos AG
Allerg Immunol (Paris); 2001 Oct; 33(8):315-8. PubMed ID: 11763721
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of montelukast in the treatment of cough variant asthma.
Spector SL; Tan RA
Ann Allergy Asthma Immunol; 2004 Sep; 93(3):232-6. PubMed ID: 15478381
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall.
Nayak AS; Philip G; Lu S; Malice MP; Reiss TF;
Ann Allergy Asthma Immunol; 2002 Jun; 88(6):592-600. PubMed ID: 12086367
[TBL] [Abstract][Full Text] [Related]
15. Effects of montelukast treatment on clinical and inflammatory variables in patients with cystic fibrosis.
Stelmach I; Korzeniewska A; Stelmach W; Majak P; Grzelewski T; Jerzynska J
Ann Allergy Asthma Immunol; 2005 Oct; 95(4):372-80. PubMed ID: 16279568
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy of montelukast sodium in treating infantile wheezing.
Zou YX; Zhang J; Ma C; Li J; Zai J; Guo YS
Eur Rev Med Pharmacol Sci; 2014; 18(6):775-80. PubMed ID: 24706299
[TBL] [Abstract][Full Text] [Related]
17. Do the leukotriene receptor antagonists work in children with grass pollen-induced allergic rhinitis?
Keskin O; Alyamac E; Tuncer A; Dogan C; Adalioglu G; Sekerel BE
Pediatr Allergy Immunol; 2006 Jun; 17(4):259-68. PubMed ID: 16771779
[TBL] [Abstract][Full Text] [Related]
18. Safety, tolerability, and exploratory efficacy of montelukast in 6- to 24-month-old patients with asthma.
van Adelsberg J; Moy J; Wei LX; Tozzi CA; Knorr B; Reiss TF
Curr Med Res Opin; 2005 Jun; 21(6):971-9. PubMed ID: 15969897
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and safety of montelukast in children aged 3 to 6 months.
Knorr B; Maganti L; Ramakrishnan R; Tozzi CA; Migoya E; Kearns G
J Clin Pharmacol; 2006 Jun; 46(6):620-7. PubMed ID: 16707408
[TBL] [Abstract][Full Text] [Related]
20. Effects of exercise training and montelukast in children with mild asthma.
Bonsignore MR; La Grutta S; Cibella F; Scichilone N; Cuttitta G; Interrante A; Marchese M; Veca M; Virzi' M; Bonanno A; Profita M; Morici G
Med Sci Sports Exerc; 2008 Mar; 40(3):405-12. PubMed ID: 18379200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
